4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Ischemic Attack, Transient

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Ischemic Attack, Transient in 2 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flamm, ES	2
Kim, J	2
Lin, J	2
Ransohoff, J	2

Other Studies

2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Ischemic Attack, Transient

Article	Year
Phosphodiesterase inhibitors and cerebral vasospasm. Archives of neurology, 1975, Volume: 32, Issue:8 Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Administration, Topical; Aminophylline; Animals; Cat	1975
Phosphodiesterase inhibitors and cerebral vasospasm. Transactions of the American Neurological Association, 1974, Volume: 99 Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aminophylline; Animals; Cats; Haplorhini; Ischemic A	1974